Market Value6,538,371,722
Total Holdings68
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
SYRE / Spyre Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
CBLL / CeriBell, Inc.
NTRA / Natera, Inc.
MASI / Masimo Corporation
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
GMED / Globus Medical, Inc.
CGEM / Cullinan Therapeutics, Inc.
XGN / Exagen Inc.
BBNX / Beta Bionics, Inc.
ETNB / 89bio, Inc.
GHRS / GH Research PLC
PEPG / PepGen Inc.
TENX / Tenax Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
CRGX / CARGO Therapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
ALUR / Allurion Technologies Inc.
RNA / Avidity Biosciences, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ALKS / Alkermes plc
MIST / Milestone Pharmaceuticals Inc.
GEHC / GE HealthCare Technologies Inc.
REPL / Replimune Group, Inc.
AXSM / Axsome Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
RDNT / RadNet, Inc.
DYN / Dyne Therapeutics, Inc.
TEM / Tempus AI, Inc.
WVE / Wave Life Sciences Ltd.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
OBIO / Orchestra BioMed Holdings, Inc.
DGX / Quest Diagnostics Incorporated
ADGM / Adagio Medical Holdings, Inc.
IMTX / Immatics N.V.
STOK / Stoke Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
PTGX / Protagonist Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
ARTV / Artiva Biotherapeutics, Inc.
RGNX / REGENXBIO Inc.
IDYA / IDEAYA Biosciences, Inc.
TRML / Tourmaline Bio, Inc.
ALUR / Allurion Technologies Inc.
BRKR / Bruker Corporation
EPIX / ESSA Pharma Inc.
PEN / Penumbra, Inc.
PCSC / Perceptive Capital Solutions Corp
CYTK / Cytokinetics, Incorporated
SYK / Stryker Corporation
MRUS / Merus N.V.
CGON / CG Oncology, Inc.
INSM / Insmed Incorporated
LENZ / LENZ Therapeutics, Inc.
ARVN / Arvinas, Inc.
BIOA / BioAge Labs, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CRVS / Corvus Pharmaceuticals, Inc.
PTCT / PTC Therapeutics, Inc.
GKOS / Glaukos Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
IMUX / Immunic, Inc.
DNTH / Dianthus Therapeutics, Inc.
SLRN / Acelyrin, Inc.
ROIV / Roivant Sciences Ltd.
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
NGNE / Neurogene Inc.
XNCR / Xencor, Inc.
AKRO / Akero Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
RAPT / RAPT Therapeutics, Inc.
QURE / uniQure N.V.
VSTM / Verastem, Inc.
KMTS / Kestra Medical Technologies, Ltd.
BEAM / Beam Therapeutics Inc.
RCKT / Rocket Pharmaceuticals, Inc.
TSHA / Taysha Gene Therapies, Inc.
URGN / UroGen Pharma Ltd.
ORKA / Oruka Therapeutics, Inc.